Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year - CNBC
 

Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year CNBCSales of psoriasis treatments and cancer drugs helped Johnson & Johnson beat Wall Street analysts' fourth-quarter earnings and revenue expectations.
View full coverage on Google News

More...